CD69 and melanoma: Despite the differences in tumor outgrowth and LN metastasis exhibited by these tumors, we observed equivalent upregulation of the early activation marker CD69 on OT‐I cells in response to both melanomas at all stages of tumor progression analyzed (Figure 2c).